CpaA a novel protease from Acinetobacter baumannii clinical isolates deregulates blood coagulation

FEMS Microbiology Letters

Volumn 356, Issue 1, 2014, Pages 53-61

  Tilley, Derek ^a,b   Law, Robert ^a   Warren, Sarah ^c   Samis, John A ^c   Kumar, Ayush ^c,d  

^a CENTENNIAL COLLEGE   (Canada)

^b ALBERTA HEALTH SERVICES   (Canada)

^c UNIVERSITY OF ONTARIO INSTITUTE OF TECHNOLOGY   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Bacterial infection; Blood clot; Factor V; Fibrinogen; Virulence factor

Indexed keywords

COAGULATION TARGETING METALLOENDOPEPTIDASE OF ACINETOBACTER BAUMANNII; FIBRINOGEN; METALLOPROTEINASE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN;

ACINETOBACTER BAUMANNII; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BLOOD CLOTTING; CONTROLLED STUDY; CPAA GENE; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; IN VITRO STUDY; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; ACINETOBACTER INFECTION; BLOOD; CHEMISTRY; ENZYME ACTIVE SITE; ENZYMOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN DEGRADATION; SEQUENCE ANALYSIS;

ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS);

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BACTERIAL PROTEINS; BLOOD COAGULATION; CATALYTIC DOMAIN; CONSERVED SEQUENCE; FIBRINOGEN; HUMANS; METALLOENDOPEPTIDASES; PARTIAL THROMBOPLASTIN TIME; PROTEOLYSIS; SEQUENCE ANALYSIS, PROTEIN;

EID: 84903894108     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/1574-6968.12496     Document Type: Article

References (42)

1. Bates SM & Weitz JI (2005) Coagulation assays. Circulation 112: e53-e60.
2. Bergeron MG, Robert J & Beauchamp D (1993) Pharmacodynamics of antibiotics in fibrin clots. J Antimicrob Chemother 31(suppl D): 113-136.
3. Bitrain M, Solari CM, Gonzalez RH & Nudel CB (2012) Identification of virulence markers in clinically relevant strains of Acinetobacter genospecies. Int Microbiol 15: 79-88.
4. Bjarnason JB & Fox JW (1995) Snake venom metalloendopeptidases: reprolysins. Methods Enzymol 248: 345-368.
5. Bloom JW, Nesheim ME & Mann KG (1979) A rapid technique for the preparation of factor V deficient plasma. Thromb Res 15: 595-599.
6. Boyer HW & Roulland-Dussoix D (1969) A complementation analysis of the restriction and modification of DNA in Escherichia coli. J Mol Biol 41: 459-472.
7. Bradford MM (1976) Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
8. Brunder W, Schmidt H & Karch H (1997) EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. Mol Microbiol 24: 767-778.
9. Center for Disease Control and Prevention (2013) Antibiotic Resistance Threats in the United States, 2013. U.S. Department of Health and Human Services, http://www.cdc.gov/drugresistance/threat-report-2013/index.html.
10. Choi KH & Schweizer HP (2005) An improved method for rapid generation of unmarked Pseudomonas aeruginosa deletion mutants. BMC Microbiol 23: 30-41.
11. Choi CH, Lee EY, Lee YC, Park TI, Kim HJ, Hyun SH, Kim SA, Lee SK & Lee JC (2005) Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell Microbiol 7: 1127-1138.
12. Delvaeye M & Conway EM (2009) Coagulation and innate immune responses: can we view them separately? Blood 114: 2367-2374.
13. Fernando D, Zhanel G & Kumar A (2013) Antibiotic resistance and expression of resistance-nodulation-division pump- and outer membrane porin-encoding genes in Acinetobacter species isolated from Canadian hospitals. Can J Infect Dis Med Microbiol 24: 17-21.
14. Gibson DG, Young L, Chuang RY, Venter JC, Hutchison CA 3rd & Smith HO (2009) Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods 6: 343-345.
15. Gomis-Ruth FX (2009) Catalytic domain architecture of metzincin metalloproteases. J Biol Chem 284: 15353-15357.
16. Gordon NC & Wareham DW (2010) Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int J Antimicrob Agents 35: 219-226.
17. Herrero M, de Lorenzo V & Timmis KN (1990) Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in gram negative bacteria. J Bacteriol 172: 6557-6567.
18. Imamura T, Potempa J, Pike RN, Moore JN, Barton MH & Travis J (1995) Effect of free and vesicle bound cysteine proteinases of Porphyromonas gingivalis on plasma clot formation: implication for bleeding tendency at periodontitis sites. Infect Immun 63: 4877-4882.
19. Imamura T, Nitta H, Yoshihiro W, Kobayashi H & Okamoto K (2008) Impaired plasma clottability induction through fibrinogen degradation by ASP, a serine protease released from Aeromonas sobria. FEMS Microbiol Lett 284: 35-42.
20. Jin JS, Kwon SO, Moon DC, Gurung M, Lee JH, Kim SI & Lee JC (2011) Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles. PLoS One 6: e17027-e17036.
21. Joly-Guillou ML (2005) Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 11: 868-873.
22. King LB, Pangburn MK & McDaniel LS (2013) Serine protease PKF of Acinetobacter baumannii results in serum resistance and suppression of biofilm formation. J Infect Dis 207: 1128-1134.
23. Kumar A, Dalton C, Cortez-Cordova J & Schweizer HP (2010) Mini-Tn7 vectors as genetic tools for single copy gene cloning in Acinetobacter baumannii. J Microbiol Methods 82: 296-300.
24. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
25. Leung WS, Chu CM, Tsang KY, Lo FH, Lo KF & Ho PL (2006) Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome. Chest 129: 102-109.
26. Loof TG, Mörgelin M, Johansson L, Oehmcke S, Olin AI, Dickneite G, Norrby-Teglund A, Theopold U & Herwald H (2011) Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense. Blood 118: 2589-2598.
27. Mann KG, Nesheim ME, Tracy PB, Hibbard LS & Bloom JW (1982) Assembly of the prothrombinase complex. Biophys J 37: 106-107.
28. Massberg S, von Grahl L, Bruehl ML et al. (2010) Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nature 16: 887-897.
29. Opal SM & Esmon CT (2003) Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care 7: 23-38.
30. Russo TA, MacDonald U, Beanan JM, Olson R, Macdonald IJ, Sauberan SL, Luke NR, Schultz LW & Umland TC (2009) Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo. J Infect Dis 199: 513-521.
31. Russo TA, Luke NR, Beanan JM, Olson R, Sauberan SL, MacDonald U, Schultz LW, Umland TC & Campagnar AA (2011) The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect Immun 78: 3993-4000.
32. Sambrook J & Russell D (2001) Molecular cloning. A Laboratory Manual, 3rd edn. Cold Spring Harbor Lab. Press, Cold Spring Harbor, NY.
33. Samis JA, Stewart KA, Nesheim ME & Taylor FB Jr (2007) Factor V cleavage and inactivation are temporally associated with elevated elastase during experimental sepsis. J Thromb Haemost 5: 2559-2561.
34. Soares AJC, Satos MF, Trugilho MRO, Neves-Ferreira AGC, Perales J & Domont GB (2009) Differential proteomics of the plasma of individuals with sepsis caused by Acinetobacter baumannii. J Proteomics 73: 267-278.
35. Sodeinde OA, Sample AK, Brubaker RR & Goguen JD (1988) Plasminogen activator/coagulase gene of Yersinia pestis is responsible for degradation of plasmid-encoded outer membrane proteins. Infect Immun 56: 2749-2752.
36. Sodeinde OA, Subrahmanyam YV, Stark K, Quan T, Bao Y & Goquen JD (1992) A surface protease and the invasive character of plague. Science 258: 1004-1007.
37. Sun H, Wang X, Degen JL & Ginsburg D (2009) Reduced thrombin generation increases host susceptibility to group A streptococcal infection. Blood 113: 1358-1364.
38. Suomalainen M, Haiko J, Ramu P, Lobo L, Kukkonen M, Westerlund-Wikstrom B, Virkola R, Lahteenmaki K & Korhonene TK (2007) Using every trick in the book: the Pla surface protease of Yersinia pestis. Adv Exp Med Biol 603: 268-278.
39. Tayabali AF, Nguyen KC, Shwed PS, Crosthwait J, Coleman G & Seligy VL (2012) Comparison of the virulence potential of Acinetobacter strains from clinical and environmental sources. PLoS One 7: e37024-e37035.
40. Tilley D, Levit I & Samis JA (2012) Measurement of Factor V activity in human plasma using a microplate coagulation assay. J Vis Exp 67: 1-7.
41. van Deuren M, Brandtzaeg P & van der Meer JW (2000) Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 13: 144-166.
42. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhard K, Gerlach H, Moreno R, Carlet J, Le Gall JR & Payen D (2009) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34: 344-353.